Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis.

Susana CoimbraSusana RochaHenrique NascimentoMaria João ValenteCristina CatarinoPetronila Rocha-PereiraMaria Sameiro-FariaJosé Gerardo OliveiraJosé MadureiraJoão Carlos FernandesVasco MirandaLuís BeloElsa Bronze-da-RochaAlice Santos-Silva

Published in: Clinical kidney journal (2020)

Our data show cfDNA to be a valuable predictive marker of prognosis in ESRD patients on dialysis treatment; high levels of cfDNA were associated with a poor outcome.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
smoking cessation
combination therapy